AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 204.36B |
| Enterprise value | 228.76B |
| Trailing P/E | 102.39 |
| Forward P/E | 17.45 |
| PEG ratio (5-yr expected) | 1.30 |
| Price/sales (ttm) | 4.53 |
| Price/book (mrq) | 5.78 |
| Enterprise value/revenue | 5.07 |
| Enterprise value/EBITDA | 26.67 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.23 |
| 52-week change 3 | 14.07% |
| S&P500 52-week change 3 | -8.47% |
| 52-week high 3 | 72.12 |
| 52-week low 3 | 52.65 |
| 50-day moving average 3 | 68.19 |
| 200-day moving average 3 | 64.15 |
Share statistics
| Avg vol (3-month) 3 | 5.08M |
| Avg vol (10-day) 3 | 7.02M |
| Shares outstanding 5 | 3.1B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 3.09B |
| % held by insiders 1 | 0.06% |
| % held by institutions 1 | 18.31% |
| Shares short (12 Jan 2023) 4 | 5.03M |
| Short ratio (12 Jan 2023) 4 | 1.18 |
| Short % of float (12 Jan 2023) 4 | N/A |
| Short % of shares outstanding (12 Jan 2023) 4 | 0.16% |
| Shares short (prior month 14 Dec 2022) 4 | 4.93M |
Dividends & splits
| Forward annual dividend rate 4 | 1.45 |
| Forward annual dividend yield 4 | 2.28% |
| Trailing annual dividend rate 3 | 2.90 |
| Trailing annual dividend yield 3 | 4.56% |
| 5-year average dividend yield 4 | 2.90 |
| Payout ratio 4 | 226.56% |
| Dividend date 3 | 11 Sept 2022 |
| Ex-dividend date 4 | 10 Aug 2022 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 26 Jul 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 4.52% |
| Operating margin (ttm) | 22.55% |
Management effectiveness
| Return on assets (ttm) | 6.32% |
| Return on equity (ttm) | 5.45% |
Income statement
| Revenue (ttm) | 45.16B |
| Revenue per share (ttm) | 14.58 |
| Quarterly revenue growth (yoy) | 11.30% |
| Gross profit (ttm) | 27.61B |
| EBITDA | 13.65B |
| Net income avi to common (ttm) | 2.04B |
| Diluted EPS (ttm) | 0.64 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.52B |
| Total cash per share (mrq) | 1.46 |
| Total debt (mrq) | 31.27B |
| Total debt/equity (mrq) | 88.97 |
| Current ratio (mrq) | 0.81 |
| Book value per share (mrq) | 11.35 |
Cash flow statement
| Operating cash flow (ttm) | 8.83B |
| Levered free cash flow (ttm) | 10.39B |
© 2023 Yahoo. All rights reserved.
